EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fibroblast growth factor 9 activates fibroblast activation and drives the progress of shoulder stiffness

Jian Xu, Weihan Yu, Yunkang Kang, Dongqiang Yang, Yanlong Liu, Wenzhi Bi, Haiyang Yu, Beijie Qi, Biao Guo

Frontiers in Cell and Developmental Biology · 30.12.2025 · 13

DOI: 10.3389/fcell.2025.1731453 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 30.12.2025. Verfasst von Jian Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Sports Medicine and Arthroscopy, Fuyang People's Hospital Affiliated to Anhui Medical University, Fuyang, Anhui, China. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Shoulder stiffness (SS) is a common disease that causes pain and restricted range of motion (ROM), involving synovial inflammation and joint capsule fibrosis. The specific pathogenesis of SS remains unclear. This study aimed to delineate the key molecular driving capsule fibrosis in SS.

Methods

Joint capsule samples from SS and non-SS patients were collected, and high-throughput RNA sequencing along with bioinformatic analysis were performed. A mouse SS model was established via joint immobilization. Functional and immunofluorescence assay were conducted on NIH3T3s. LY294002 was used both in NIH3T3s and mouse SS models.

Results

Transcriptomic analysis identified 100 differentially expressed genes (DEGs). Among the top hub genes, FGF9 was notably upregulated in the SS capsules. In vitro , FGF9 promoted NIH3T3s migration, proliferation, and α-SMA expression, effects that were reversed by LY294002. In vivo , intra-articular LY294002 injection reduced capsule thickening, fibrosis, and improved passive ROM in SS mice.

Conclusion

Our findings revealed that FGF9 drove fibroblast activation and joint capsule fibrosis in SS via the PI3K/Akt signaling pathway. Targeted inhibition of the PI3K/Akt signaling might represent a promising therapeutic strategy for SS.

Schlagwörter

Stichwörter der Autor:innen

FGF9PI3K/AKTfibrosisshoulder stiffnesstranscriptomics

Autor:innen und Institutionen

  • Department of Orthopaedics, Sports Medicine and Arthroscopy, Fuyang People's Hospital Affiliated to Anhui Medical University, Fuyang, Anhui, China.
  • Department of Sports Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Orthopedics, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, China.

Zitieren

APA

Xu, J., Yu, W., Kang, Y., Yang, D., Liu, Y., Bi, W., Yu, H., Qi, B., & Guo, B. (2025). Fibroblast growth factor 9 activates fibroblast activation and drives the progress of shoulder stiffness. Frontiers in Cell and Developmental Biology, 13. https://doi.org/10.3389/fcell.2025.1731453

Vancouver

Xu J, Yu W, Kang Y, Yang D, Liu Y, Bi W, et al. Fibroblast growth factor 9 activates fibroblast activation and drives the progress of shoulder stiffness. Frontiers in Cell and Developmental Biology. 2025;13. doi:10.3389/fcell.2025.1731453

BibTeX
@article{Xu2025,
  author = {Xu, Jian and Yu, Weihan and Kang, Yunkang and Yang, Dongqiang and Liu, Yanlong and Bi, Wenzhi and Yu, Haiyang and Qi, Beijie and Guo, Biao},
  title = {Fibroblast growth factor 9 activates fibroblast activation and drives the progress of shoulder stiffness},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2025},
  volume = {13},
  doi = {10.3389/fcell.2025.1731453}
}
Kostenlos starten →